Home Authors Posts by Sarah Pringle

Sarah Pringle

Having nearly sealed a deal a year ago to sell Jordan Health Services, Palladium Equity Partners is gearing up to take the home-care and hospice provider back to market for a third time, Buyouts has learned. The firm has not selected a financial adviser to conduct a sales process for the Texas company, but it’s […]
First-round bids for Clearview Capital’s St. Croix Hospice are due this week, according to two sources familiar with the matter. Healthcare-focused investment bank Cain Brothers is lead financial adviser on the sales process for the Midwest-concentrated provider of hospice-care services, while healthcare boutique advisory firm Triple Tree is co-advising, Buyouts has learned. The process for […]
Audax Private Equity prevailed in the auction for Altasciences Clinical Research, one of the largest independent providers of services that support early-phase drug development for biotech and pharma companies. The seller is Toronto sponsor Kilmer Capital, which took its initial majority stake in Algorithme Pharma in 2007. The company bulked up in May 2013 through its acquisition […]
Premier Home Health Care Services Inc, the New York-concentrated provider of primarily non-medical senior-home-care services, is exploring a sale, according to four sources familiar with the matter. JP Morgan Securities is financial adviser to the White Plains, New York, home-care company, the sources said. Premier is being marketed to sponsors and strategics, two of the […]
MedXM, the provider of in-home health assessments used to bill Medicare, is seeking a private equity partner, according to four sources familiar with the matter. JMP Securities is conducting the sponsor-focused sales process for the founder-owned company, the sources said. Second-round bids for MedXM are due the third week of June, one source said. MedXM […]
As capital continues to flood into the healthcare market, traditional PE buyers are increasingly looking for ways to preempt formal auctions while sellers are opting for more focused processes, sponsors said at the Jefferies 2017 Healthcare Conference. More family offices, European funds, LP direct investments and consumer-focused investors are contributing to what has become a hypercompetitive […]
Carlyle, GTCR, Albany Molecular, private equity, merger, M&A, healthcare
Another pair of bulge-bracket sponsors are injecting capital into clinical-trial services, underscoring interest in a segment that has seen a strong flow of dealmaking in recent years. Carlyle Group and GTCR teamed up to acquire Albany Molecular Research, a global contract research and management company serving the pharma and biotech industries. The investors agreed to […]
Bain Capital Ventures, private equity, merger, M&A, healthcare, Medicare, Medicaid, Tom Price, HHS
The continued transition toward value-based care bodes well for Remedy Partners, the VC-backed company currently exploring a sale, four people familiar with the matter said. The Bain Capital Ventures-backed “episodes of care” company has turned to JPMorgan Securities for financial advice, said three of the sources. The Darien, Connecticut, company could be either a sponsor […]
TPG Capital’s bold effort to ensure a clear victory for home-health-software company Kinnser underscores the importance of buyer differentiation in today’s competitive healthcare market. Preempting what was expected to produce a robust sales process among sponsors, TPG struck a deal to buy Kinnser through Mediware Information Systems. It was only in February that TPG completed […]
Goldman Sachs has invested in California Skin Institute, the state’s largest dermatology practice, four sources told Buyouts. The investment is understood to have come from the private capital investing unit of Goldman’s Special Situation Group, said three of the sources. While the size of the investment is uncertain, Goldman’s private capital investment platform offers junior […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination